Taurine treatment inhibits CaMKII activity and modulates the presence of calbindin D28k, calretinin, and parvalbumin in the brain.
about
Taurine and central nervous system disorders.Neuroprotective Mechanisms of Taurine against Ischemic Stroke.The effects of oral taurine administration on behavior and hippocampal signal transduction in rats.Decrease of calbindin-d28k, calretinin, and parvalbumin by taurine treatment does not induce a major susceptibility to kainic acid.Effects and Mechanisms of Taurine as a Therapeutic Agent.
P2860
Taurine treatment inhibits CaMKII activity and modulates the presence of calbindin D28k, calretinin, and parvalbumin in the brain.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Taurine treatment inhibits CaM ...... and parvalbumin in the brain.
@en
Taurine treatment inhibits CaM ...... and parvalbumin in the brain.
@nl
type
label
Taurine treatment inhibits CaM ...... and parvalbumin in the brain.
@en
Taurine treatment inhibits CaM ...... and parvalbumin in the brain.
@nl
prefLabel
Taurine treatment inhibits CaM ...... and parvalbumin in the brain.
@en
Taurine treatment inhibits CaM ...... and parvalbumin in the brain.
@nl
P2093
P2860
P50
P356
P1476
Taurine treatment inhibits CaM ...... and parvalbumin in the brain.
@en
P2093
P2860
P304
P356
10.1002/JNR.22192
P577
2010-01-01T00:00:00Z